Improved neuroprotective effect of methylene blue with hypothermia after porcine cardiac arrest
Related Experiment Video
Updated: May 12, 2026
In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
L Wiklund1, F Zoerner, E Semenas
1Departments of Surgical Sciences/Anesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden. lars.wiklund@surgsci.uu.se
Background:
Induced mild hypothermia and administration of methylene blue (MB) have proved to have neuroprotective effects in cardiopulmonary resuscitation (CPR); however, induction of hypothermia takes time. We set out to determine if MB administered during CPR could add to the histologic neuroprotective effect of hypothermia.
Methods:
A piglet model of extended cardiac arrest (12 min of untreated cardiac arrest and 8 min of CPR) was used to assess possible additional neuroprotective effects of MB when administered during CPR before mild therapeutic hypothermia induced 30 min after restoration of spontaneous circulation (ROSC). Three groups were compared: C group (n = 8) received standard CPR; PH group (n = 8) received standard CPR but 30 min after ROSC these piglets were cooled to 34°C; the PH+MB group (n = 8) received an MB infusion 1 min after commencement of CPR and the same cooling protocol as the PH group. Three hours later, the animals were killed. Immediately after death, the brains were harvested pending histological and immunohistological analysis.
Results:
Circulatory variables were similar in the groups except that cardiac output was greater in the PH+MB group 2-3 h after ROSC. Cerebral cortical neuronal injury and blood-brain barrier disruption was greatest in the C group and least in the MB group. The neuroprotective effect of MB and hypothermia was significantly greater than that of delayed hypothermia alone.
Conclusion:
Administration of MB during CPR added to the short term neuroprotective effects of induced mild hypothermia induced 30 min after ROSC.
Insights
Methylene blue (MB) given during cardiopulmonary resuscitation (CPR) enhances the neuroprotective effects of hypothermia. This combination offers greater brain protection than hypothermia alone after cardiac arrest.
Area of Science:
- Cardiology
- Neuroscience
- Pharmacology
Background:
- Mild hypothermia and methylene blue (MB) show neuroprotective effects post-cardiopulmonary resuscitation (CPR).
- Inducing hypothermia requires time, potentially limiting its immediate benefit.
Purpose of the Study:
- To investigate if MB administered during CPR enhances the neuroprotective effects of subsequent hypothermia.
- To evaluate the histologic neuroprotection offered by MB in conjunction with hypothermia.
Main Methods:
- A piglet model of cardiac arrest (12 minutes) followed by CPR (8 minutes) was utilized.
- Three groups were compared: standard CPR (C), CPR with hypothermia post-restoration of spontaneous circulation (PH), and CPR with MB infusion during CPR followed by hypothermia (PH+MB).
- Brains were analyzed histologically and immunohistologically three hours after restoration of spontaneous circulation.
Main Results:
- The PH+MB group exhibited greater cardiac output 2-3 hours post-ROSC compared to other groups.
- Cerebral cortical neuronal injury and blood-brain barrier disruption were significantly reduced in the PH+MB group.
- The combined effect of MB and hypothermia provided superior neuroprotection compared to hypothermia alone.
Conclusions:
- Methylene blue administration during CPR significantly augmented the short-term neuroprotective effects of induced mild hypothermia.
- This combination therapy shows promise for improving neurological outcomes after cardiac arrest.
